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Abstract
Endothelial precursor cells respond to molecular cues to migrate and assemble into embryonic blood vessels, but the signaling pathways
involved in vascular patterning are not well understood. We recently showed that avian vascular patterning cues are recognized by
mammalian angioblasts derived from somitic mesoderm through analysis of mouse–avian chimeras. To determine whether stem cell-derived
endothelial cells/progenitors also recognize global patterning signals, murine ES cell-derived embryoid bodies (EBs) were grafted into avian
hosts. ES cell-derived murine endothelial cells/progenitors migrated extensively and colonized the appropriate host vascular beds. They also
formed mosaic vessels with avian endothelial cells. Unlike somite derived-endothelial cells, ES cell-derived endothelial cells/progenitors
migrated across the host embryonic midline to the contralateral side. To determine the role of VEGF signaling in embryonic vascular
patterning, EBs mutant for a VEGF receptor (flk-1/) or a signal (VEGF-A/) were grafted into quail hosts. Flk-1/ EB grafts produced
only rare endothelial cells that did not migrate or assemble into vessels. In contrast, VEGF-A/ EB grafts produced endothelial cells that
resembled wild-type and colonized host vascular beds, suggesting that host-derived signals can partially rescue mutant graft vascular
patterning. VEGF-A/ graft endothelial cells/progenitors crossed the host midline with much lower frequency than wild-type EB grafts,
indicating that graft-derived VEGF compromised the midline barrier when present. Thus, ES cell-derived endothelial cells/progenitors
respond appropriately to global vascular patterning cues, and they require the VEGF signaling pathway to pattern properly. Moreover,
EB–avian chimeras provide an efficient way to screen mutations for vascular patterning defects.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Early elegant descriptions of vascular development
(Sabin, 1917; Clark and Clark, 1939) resulted in a model of
blood vessel formation that is still useful today (reviewed in
Poole and Coffin, 1989; Risau, 1997; Drake et al., 1998;
Daniel and Abrahamson, 2000). Blood vessels form devel-
opmentally by two processes—vasculogenesis and angio-
genesis. Vasculogenesis is the coalescence and differentia-
tion of mesodermal precursor cells to form vessels, and
angiogenesis involves the migration and division of already
differentiated endothelial cells to form new vasculature.
This primary vascular plexus is then remodeled by interac-
tions between endothelial cells and other mesodermal cells,
primarily smooth muscle cells and pericytes (Orlidge and
D’Amore, 1987). These processes are coordinated with
other developmental events by vascular patterning cues that
instruct blood vessels where and when to form.
The cellular and molecular processes that control vascu-
lar patterning are largely unknown. Genetic analyses in
mice and zebrafish suggest that the Notch, ephrin, and EDG
pathways, as well as unidentified genes such as out-of-
bounds, are involved in patterning the primary vascular
plexus (reviewed in Hogan and Kolodziej, 2002) (Pereria et
al., 1999; Zhong et al., 2000; Graef et al., 2001; Childs et
al., 2002). Unfortunately, the early lethality of mice carry-
ing VEGF pathway mutations has prevented rigorous ge-
netic evaluation of VEGF signaling in mammalian vascular
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patterning. However, endothelial cells have morphogenetic
properties that are regulated by VEGF, suggesting involve-
ment in vascular patterning. Moreover, several studies
firmly link VEGF expression by astrocytes and neurons to
local vessel patterning in the retina and limb (Stone et al.,
1995; Zhang et al., 1999; Mukuoyama et al., 2002; Otani et
al., 2002).
Embryological approaches have provided clues to vas-
cular patterning constraints in the embryo. The seminal
work of Noden established that avian angioblasts are highly
Fig. 1. Mouse embryoid body (EB) placement in an avian host and in vitro differentiation. (A) Day 3–4 murine EBs were labeled with Nile Blue, then placed
on one side of the presomitic mesoderm cavity of an 11-somite (HH stage 10) quail host and photographed in ovo. Arrow points to EBs and the graft site.
(B–D) EBs of different genotypes were allowed to differentiate in vitro to day 7 (analogous to the age of EBs in grafts when analyzed), then stained for
PECAM-1 in whole mount. (B) Wild-type EB; (C) VEGF-A/ EB; (D) flk-1/ EB. The arrow in (B) points to the vascular plexus, while in (C) and (D),
the arrows point to PECAM-positive clumps of angioblasts.
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migratory and originate from most embryonic tissues (No-
den, 1989). Subsequent work using quail-chick chimeras
showed that: (1) avian somites are a source of angioblasts
that migrate extensively and colonize vascular beds of the
trunk and limb; and (2) avian angioblasts are restricted from
crossing the axial midline and colonizing the contralateral
side of the embryo (Wilting et al., 1995; Pardanaud et al.,
1996). We recently extended these results to mammalian
vascular cells using mouse–avian chimeras, and we showed
that mouse somite-derived angioblasts respond to avian
patterning signals (Ambler et al., 2001).
The recent interest in stem cells as a possible source of
endothelial cells capable of providing therapeutic relief led
us to consider whether ES cell-derived endothelial cells
and/or their progenitors (endothelial cells/progenitors)
could respond to vascular pattern cues. Here, we demon-
strate that ES cell-derived endothelial cells/progenitors mi-
grate and pattern in response to embryonic vascular pattern-
ing signals. Genetic dissection of VEGF signaling in this
process revealed a critical role for the VEGF receptor flk-1.
The VEGF-A ligand was also important, but host-derived
signals could partially rescue VEGF-A/ endothelial cell
patterning. Our novel use of ES cell-derived embryoid body
grafts in avian hosts should provide an efficient way to
screen mutations for vascular patterning defects.
Materials and methods
ES cells
R1, ROSA (ROSA26/), flt-1 hemizygous (flt-1/),
flk-1 hemizygous (flk-1/) VEGF mutant (VEGF-A/),
and homozygous flk-1 mutant (flk-1/) ES cells were cul-
tured and differentiated into embryoid bodies (EBs) as pre-
viously described (Wang et al., 1992; Bautch, 2002). At day
Fig. 2. EB grafts incorporate and produce vasculature in avian hosts. Day 3 EBs were placed in quail hosts as in Fig. 1, then incubated in ovo for 3–4
additional days. (A) ROSA26/ (wild-type) EB–avian chimera whole mount stained for -gal reactivity (blue). Day 4 EBs were placed into a 14-somite (HH
stage 11) host and incubated for 3 days, to HH stage 24. The dashed line outlines the limb, and the arrow points to -gal-positive graft tissue. The inset
is a higher magnification of the same graft. The arrow points to extensions from the graft proper that resemble blood vessels, and the arrowheads point to
small clumps of graft cells that are distinct from the graft body. (B) Wild-type EB-avian chimera whole mount stained for PECAM (purple) to visualize
graft-derived vasculature. Day 3 EBs were placed into a 19-somite (HH stage 13) host and incubated for 3 days, to HH stage 25. The inset is a higher
magnification of the same graft. The arrow points to a graft-derived vessel in the vertebral area of the quail host.
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3 or 4 of differentiation, EBs were implanted into avian
hosts. Some EBs were cultured for an additional 3-4 days
(to day 6 or 7 of differentiation) prior to fixation.
Chimeras
Fertilized Japanese quail eggs (CBT Farms, Chester-
town, MD) were incubated at 37°C for 2 days prior to
surgery. The HH 10 stage (Hamburger and Hamilton, 1951)
quail hosts were prepared in ovo. The vitelline membrane
was peeled back, and the quail presomitic mesoderm was
removed by using sharpened tungsten needles.
Day 3 or 4 EBs were removed from tissue culture me-
dium and rinsed in Ringer’s solution. EBs were then labeled
with 1% Nile Blue (Sigma) by using a glass needle, and one
to three EBs were positioned within the cavity of the host
made by removal of the presomitic mesoderm. The chimeric
embryos were sealed with Parafilm and allowed to incubate
for 3 or 4 days at 37°C in a humidified incubator. For time
course experiments, EBs were incubated with 0.2 ng/ml
CM-Dil (Molecular Probes, Eugene, OR) added to the cul-
ture medium during culture in vitro. EBs were incubated in
200 ng/ml CM-Dil in PBS for 5 min immediately prior to
implantation. Chimeras were analyzed at 18, 24, or 36 h
postsurgery as described below, and fluorescence was visu-
alized with an Olympus IX 50 inverted microscope.
-Galactosidase detection and immunohistochemistry
Embryos were processed for whole-mount -galactosi-
dase detection and immunohistochemistry as previously de-
scribed (Ambler et al., 2001). Briefly, for -galactosidase
detection (adapted from Beddington et al., 1989), embryos
were sacrificed 3 or 4 days postsurgery, rinsed in PBS, and
fixed in 4% paraformaldehyde (PFA) for 20 min at room
temperature. Chimeras were washed two times for 10 min in
wash buffer [0.1 M phosphate buffer (pH 7.3), 0.1% sodium
desoxycholate, 0.02% NP40, 0.05% BSA (Sigma)], then
transferred to wash buffer containing 1 mg/ml X-gal
(Sigma), 5 mM ferrocyanide, and 5 mM ferricyanide. After
incubation for 14–18 h at 37°C in the dark, embryos were
postfixed in 4% PFA and stored at 4°C until embedded.
For whole-mount immunohistochemistry (adapted from
Dent et al., 1989), chimeric embryos were fixed for 24–72
h in 4% PFA at 4°C, dehydrated through a MeOH series,
and stored in 100% MeOH at20°C. They were exposed to
3% H2O2/MeOH overnight at 4°C, followed by rehydration
to PBS. Embryos were incubated for 10 min in a solution of
1 g/ml proteinase K (Sigma) in 50 mM Tris (pH 8.0)/5
mM EDTA, and washed for 5 min in 2 mg/ml glycine in
PBS/0.1% Tween 20 (PBT). After blocking overnight at
4°C in TBSTN [Tris-buffered saline (pH 7.5)/0.05% Tween
20 (TBST)/20% heat-inactivated FCS], the chimeric em-
bryos were incubated overnight at 4°C with rat anti-mouse
PECAM (MEC 13.3; BD Pharmingen) at 1:200 in TBSTN.
Five 1-h washes in TBST were followed by addition of
HRP-conjugated goat anti-rat secondary antibody (Pierce)
at 1:200 in TBSTN. After incubation overnight at 4°C,
embryos were washed five times for 1 h each in TBST at
room temperature followed by an overnight wash in TBST
at 4°C. The antibody was detected by incubation in PBS/0.5
mg/ml DAB (Sigma)/0.03% H2O2/3 mg/ml NiSO4 for 30
min, resulting in a purple reaction product. Sometimes the
NiSO4 was eliminated to yield a brown reaction product.
For whole-mount immunohistochemical staining of
embryoid bodies (EBs), they were fixed, dehydrated, and
stored as described for chimeric embryos. EBs were
rehydrated in a MeOH/PBS series, exposed to 1 M gly-
cine/PBS for 30 min, followed by two 15-min washes in
PBS, then treated with 6% H2O2/PBS for 25 min. They
were rinsed in PBT two times for 15 min, then perme-
abilized with 10 g/ml proteinase K (Sigma) in PBS for
3 min, followed by 2 mg/ml glycine in PBT for 5 min.
After washing three times for 5 min in PBT, EBs were
blocked in PBT/5% heat-inactivated FCS (PBTN) for 30
min at room temperature. They were incubated overnight
at 4°C with rat anti-mouse PECAM (MEC 13.3) at 1:200
in PBTN. EBs were washed for 2 h in PBT, then incu-
bated overnight at 4°C with an HRP-conjugated goat
anti-rat secondary antibody at 1:200 in PBTN. After the
overnight incubation, EBs were rinsed in PBT for 2 h.
Detection was by incubation in PBS/0.33 mg/ml DAB
(Sigma)/0.006% H2O2/3 mg/ml NiSO4 for 5 min, result-
ing in a purple reaction product. EBs were rinsed and
stored in PBS until photographed. Chimeric embryos and
EBs were visualized and photographed with an Olympus
SZH10 dissecting microscope.
Embryos were embedded and sectioned as previously
described (Ambler et al., 2001). Briefly, embryos were
dehydrated through a MeOH series and then transferred to
100% EtOH for 20 min. The embryos were incubated in
50% EtOH/xylenes, 100% xylenes, 50% xylenes/50% par-
affin for 30 min each, then incubated with melted paraffin at
58°C for 24–48 h. The paraffin was solidified at room
temperature, and 12-m transverse sections were cut on a
microtome.
For QH1 staining, dried sections were cleared in Histo-
clear (National Diagnostics) before rehydrating through an
EtOH series. Slides were rinsed in PBS, then exposed to
0.23% H2O2/PBS for 15 min. Slides were incubated over-
night at 4°C with a 1:200 dilution of QH1 (Developmental
Studies Hybridoma Bank, Iowa City, IA) in PBS/5% goat
serum. Slides were rinsed in PBS for 15–20 min followed
by a 2-h incubation of HRP-conjugated goat anti-mouse IgG
(Jackson ImmunoResearch) in PBS/5% goat serum and a
DAB/H2O2 reaction as described for staining of chimeric
embryos. Slides were mounted with Glycergel (Dako) and
visualized with a Nikon Opitphot 2 microscope.
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Results
Stem cell-derived endothelial cells/progenitors migrate
and pattern properly in the avian host
Differentiation of murine ES cells in vitro leads to a
programmed differentiation of several cell types, including
endothelial cells. We took advantage of this model to assess
the behavior of ES cell-derived murine endothelial cells
and/or their progenitor cells (endothelial cells/progenitors)
when grafted into an avian host. Partially differentiated EBs
at days 3–4 of differentiation contain endothelial precursor
cells called angioblasts, but few if any mature endothelial
cells (Yamashita et al., 2000). One to three EBs were placed
into appropriately staged quail embryos, in a cavity made by
removal of the presomitic mesoderm from one side of the
neural tube (Fig. 1A). Companion EBs from the same dif-
ferentiation were incubated for an additional 3–4 days in
culture to determine their capacity to differentiate and form
primitive vessels in vitro (Fig. 1B–D). Mouse endothelial
cells and at least a subset of angioblasts express the vascular
marker PECAM (Baldwin et al., 1994; Redick and Bautch,
1999; Bautch et al., 2000). Wild-type EBs formed in vitro
had an extensive PECAM primitive vasculature (Fig. 1B),
while VEGF-A/ EBs and flk-1/ EBs had rare clumps of
PECAM angioblasts, but no extensive vasculature (Fig.
1C and D). These results were expected because vascular
development peaks at days 7–8 of ES cell differentiation
and is dependent on the VEGF signaling pathway (Wang et
al., 1992; Vittet et al., 1996; Shalaby et al., 1997; Fong et
al., 1999; Bautch et al., 2000; Kearney et al., 2002).
After 3 days of incubation in the quail host, ROSA26/
EBs that constitutively express -galactosidase (-gal)
showed extensive colonization of the quail embryo (Fig.
2A). Moreover, -gal-positive murine graft cells were seen
at some distance from the main body of the graft, and
-gal-positive structures with vessel morphology were seen
adjacent to the main body of the graft (inset, Fig. 2A).
Transverse sections of the ROSA26/ EB-chimeric em-
bryos showed graft survival and placement in the somitic
area, with extensive migration of graft-derived cells (Fig.
3A). Some of these cells were associated with QH1-positive
quail host vessels (Pardanaud et al., 1987), suggesting that
they were ES cell-derived endothelial cells.
Wild-type EBs (/) were grafted and incubated as
described above, and the chimeric embryos were stained in
whole mount for PECAM reactivity, since this marker of
mouse endothelial cells does not cross-react with quail vas-
cular cells (Ambler et al., 2001). The PECAM staining
pattern showed extensive murine ES cell-derived vessels at
the graft site and adjacent to it (Fig. 2B). Thus ES cell-
derived endothelial cells can differentiate and assemble into
vessels in the avian host. The pattern of PECAM-1 vessels
dorsal to the graft site suggested that graft-derived endothe-
lial cells contributed to host vascular beds in the inter-
somitic and vertebral areas (inset, Fig. 2B).
A second group of grafts was generated by using EBs
that were hemizygous for the VEGF receptor flt-1 (flt-1/),
expressing the lacZ reporter gene under control of the flt-1
promoter (Fong et al., 1995). In these EBs, -gal is ex-
pressed in cells that express flt-1, which include murine
angioblasts and endothelial cells, and there is no detectable
phenotype resulting from hemizygosity at the flt-1 locus
(Fong et al., 1996; Kearney et al., 2002). Analysis of trans-
verse sections of the flt-1/ EB-chimeric embryos coun-
terstained with QH1 showed that ES-cell derived endothe-
lial cells/progenitors migrated from the graft site and
contributed to host vascular beds (Fig. 3B–D). For example,
-gal and QH1 staining was colocalized in the intersomitic
area (Fig. 3B), the kidney rudiment (Fig. 3B), the limb (Fig.
3C), and the perineural area (Fig. 3D) of the quail host.
These sites of ES cell-derived endothelial cell coloniza-
tion corresponded to sites of colonization of presomitic
mesoderm-derived murine endothelial cells (Ambler et al.,
2001), suggesting that ES cell-derived endothelial cells/
progenitors respond to similar patterning cues in the avian
host. To obtain quantitative data, chimeric embryos contain-
ing wild-type (/) and ROSA26/ EB grafts, and flt-
1/ EB grafts, were serially sectioned in the transverse
plane, counterstained with QH1, and examined throughout
the trunk region. Graft cell contribution to the host vascular
beds described above was scored and compared with a
similar quantitation of presomitic mesoderm-derived grafts
(Ambler et al., 2001). The results are shown in Table 1.
They indicate that ES cell-derived endothelial cells are
similar to embryonic endothelial cells from the presomitic
mesoderm in contributing extensively to the host inter-
somitic, limb, kidney, and perineural vascular beds. Minor
differences include slightly lower frequencies of contribu-
tion to the perineural (82 vs. 100%) and kidney (70 vs.
100%) vascular beds by ES cell-derived endothelial cells.
The ability of ES cell-derived endothelial cells/progeni-
tors to cross the embryonic midline and colonize the con-
tralateral side of the host was also scored. In contrast to
presomitic mesoderm-derived vascular cells that never
crossed the host midline, the ES cell-derived endothelial
cells/progenitors crossed the midline 35% of the time (Fig.
3E, and Table 1). In the majority of cases, the ES cell-
derived endothelial cells were found exclusively in the
intersomitic vascular region on the contralateral side of the
host (Fig. 3E), and in rare instances, they also colonized the
contralateral perineural area (data not shown). However, ES
cell-derived endothelial cells were never seen in the con-
tralateral limb or kidney vascular beds, suggesting that
migration on the contralateral side was limited. The ability
of nonvascular ES cell-derived graft cells to cross the host
midline was not scored in these experiments.
To examine in more detail the relationship of ES cell-
derived murine endothelial cells and quail endothelial cells,
sections of chimeric embryos that carried grafts from wild-
type (/) or flt-1/ EBs that have a wild-type phenotype
were examined at higher magnification (Fig. 4). Numerous
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instances of apposition between host and graft vascular cells
were noted. For example, a small PECAM graft vessel
appeared embedded in a QH1 quail vessel, while nearby,
a putative junction between graft and host endothelial cells
was seen (Fig. 4A). In other cases, the graft vessels were
closely apposed to but largely unlinked to host vessels (Fig.
4D). -Gal-positive flt-1/ graft endothelial cells also
formed mosaic vessels (Fig. 4B and E) or were found in
close apposition to host vessels (Fig. 4C) in several vascular
beds. In rare instances, graft vessels had QH1 host cells in
the vessel lumen with hematopoietic morphology. Since
QH1 is also expressed on quail hematopoietic precursors
Fig. 3. ES cell-derived endothelial cells/progenitors migrate and pattern in avian hosts. EB–avian chimeras made with either ROSA/ (A, E) or flt-1/
(B–D) EBs that have a wild-type phenotype were whole-mount stained for -gal (blue) reactivity to visualize graft-derived cells (ROSA) or endothelial cells
(flt-1), and transverse sections were then counterstained with QH1 (brown) to visualize host blood vessels. (A) ROSA/ EB graft showing graft incorporation
into the somitic region of the host. Day 3 EBs were placed into a 15 somite (HH stage 12) host, and incubated for 4 days, to HH stage 25. The large area
of blue cells adjacent to the neural tube is graft tissue. The arrow points to graft-derived cells that appear to have migrated from the graft site and associate
with QH1-positive host vessels in the perineural area. (B) Flt/ EB graft showing graft endothelial cells in several midline host vascular beds. Day 4 EBs
were placed into a 13-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The arrows point to several of numerous areas where graft-derived
endothelial cells are found associated with QH1-positive host vessels. The upper arrow points to a mosaic vessel in the intersomitic area, and the lower arrow
points to graft-derived endothelial cells in the kidney rudiment of the host. (C) Flt/ EB graft showing graft endothelial cells in the limb. Day 4 EBs were
placed into a 13-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The arrows point to two distinct regions where graft-derived endothelial
cells appear to form mosaic vessels with host endothelial cells. (D) Flt/ EB graft showing graft endothelial cells in the perineural area. Day 4 EBs were
placed into an 11-somite (HH stage 10) host, and incubated for 3 days, to HH stage 24. The arrows point to two distinct perineural regions where
graft-derived endothelial cells are associated with host endothelial cells. (E) ROSA/ EB graft showing midline crossing of graft-derived cells. Day 4 EBs
were placed into a 10-somite (HH stage 10) host, and incubated for 3 days, to HH stage 24. The asterisk indicates the graft side of the host. The arrow below
the asterisk points to graft-derived cells associated with host intersomitic vessels on the graft side, while the arrow on the opposite side points to graft-derived
cells associated with host intersomitic vessels on the contralateral side. The arrowhead points to graft-derived cells in the perineural area on the graft side
of the host. NC, notochord; NT, neural tube. Scale bars, 50 m.
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(Pardanaud et al., 1987), this finding suggests that ES cell-
derived endothelial cells can form functional vessels and
support blood flow.
To determine whether migrating vascular cells express
endothelial lineage markers while migrating, we examined
the temporal and spatial pattern of expression of flk-1, a
marker of endothelial cells/progenitors. EBs that were
hemizygous for the VEGF receptor flk-1 (flk-1/), ex-
pressing the lacZ reporter gene under control of the flk-1
promoter (Shalaby et al., 1995), were analyzed at early
times after surgery (Fig. 5). At 12 h postsurgery, no -gal-
positive cells were seen outside the graft boundaries, as
determined by Dil labeling of the graft tissue prior to sur-
gery (data not shown). However, at 18 h postsurgery and
beyond, individual or small groups of -gal-positive cells
could be seen at sites outside the graft proper (Fig. 5A–F).
Transverse sections of graft sites at 24 h postsurgery
showed -gal-positive cells both within the graft proper and
outside the graft boundaries (Fig. 5G–L). Inspection of
adjacent sections showed that the -gal reactivity was con-
fined to a single section, suggesting that these were single
cells or very small clumps of cells in the process of migra-
Fig. 4. ES cell-derived endothelial cells associate with and form mosaic vessels with avian host vessels. Higher magnification of transverse sections of EB–
quail chimeras. (A, D, F) Wild-type EB grafts whole-mount stained for PECAM (purple). (B, C, E) flt-1/ EB grafts whole-mount stained for -gal (blue).
In all panels, sections are counterstained with QH1 (brown) to visualize host endothelial cells. (A) Vascular bed in the limb. Day 4 EBs were placed into
a 14-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The arrow points to a juxtaposition of graft and host vessels, and the arrowhead
points to the area where graft and host vessels may have joined. (B) Quail intersomitic vessel with a small clump of graft-derived vascular cells at the distal
tip. Day 4 EBs were placed into a 13-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The arrow points to the juxtaposition of graft
and host vascular cells. Inset, closeup of an adjacent section. The arrowhead points to what appears to be a junction between graft and host endothelial cells.
(C) Vascular bed in the limb. Day 4 EBs were placed into a 17-somite (HH stage 12) host, and incubated for 3 days, to HH stage 24. The arrow points
to a graft-derived vessel that is in close apposition to the adjacent host vessel. (D) Vascular bed in the intersomitic region. Day 4 EBs were placed into an
11-somite (HH stage 10) host, and incubated for 3 days, to HH stage 24. The arrow points to a graft-derived vessel that is in close apposition to the adjacent
host vessel. The arrowhead points to an area where the graft and host vessels appear to have joined. (E) Vascular bed in the kidney rudiment. Day 4 EBs
were placed into a 13-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The arrowhead points to a junction in a mosaic vessel. (F) Vascular
bed in the somitic cavity. Day 4 EBs were placed into a 17-somite (HH stage 12) host, and incubated for 3 days, to HH stage 24. Arrows point to QH1
positive quail cells that appear hematopoietic by morphology and location within a graft-derived vessel. NC, notochord. Scale bars, 10 m.
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tion. We also saw -gal-negative graft-derived cells that had
migrated from the original graft site (data not shown). In
summary, the temporal and spatial expression of -gal from
the flk-1 locus of grafted EBs suggests that some migrating
cells express flk-1, indicating that they are specified to the
vascular lineage before or during migration.
The VEGF signaling pathway is required for patterning
vessels at the embryonic midline
The availability of ES cells lacking components of the
VEGF signaling pathway allowed us to investigate how
perturbations of this pathway affect embryonic vascular
patterning. Flk-1/ ES cells lack an essential VEGF re-
ceptor, and they form reduced numbers of angioblasts and
only rare small vessels upon in vitro differentiation (Schuh
et al., 1999) (Fig. 1D). Flk-1/ EBs survived in quail
hosts, and small numbers of PECAM angioblasts were
found in clumps (Fig. 6A and B; Fig. 7A and B). Although
QH1 quail vessels were seen nearby, the flk-1/ angio-
blasts did not form connections with quail endothelial cells
or form mosaic vessels. Moreover, the rounded morphology
of the flk-1/ graft cells expressing PECAM suggested that
they did not migrate from the graft upon differentiation.
Analysis of serially sectioned grafts was consistent with a
migration defect, since flk-1/ graft endothelial cells were
never seen in the host vascular beds colonized by wild-type
murine endothelial cells (Table 1). Thus the VEGF receptor
flk-1 is required for proper migration and patterning of ES
cell-derived endothelial cells/progenitors.
VEGF-A/ ES cells also produce reduced numbers of
angioblasts and rare small vessels when differentiated in
vitro (Bautch et al., 2000). In contrast, VEGF-A/ EBs
produced endothelial cells/progenitors that migrated and
patterned in the avian host (Fig. 6C–E; Fig. 7C–F). The
VEGF-A/ EB grafts fell into two categories. Type 1
grafts were formed from small EBs, and these grafts pro-
duced an extensive graft-derived vasculature (Fig. 6C and
D; Fig. 7C and D). Type 1 VEGF-A/ endothelial cells
formed mosaic vessels with wild-type quail endothelial cells
(Fig. 7D, and inset), and they colonized host vascular beds
at frequencies similar to those of wild-type ES cell-derived
endothelial cells (Table 1). Type 2 VEGF-A/ grafts were
formed from larger EBs, and these grafts produced fewer
graft-derived vessels and more clumps of PECAM murine
cells (Fig. 6E; Fig. 7E and F). However, in contrast to the
flk-1/ endothelial cells/progenitors, the VEGF-A/ en-
dothelial cells/progenitors from Type 2 grafts appeared to
migrate to some extent (Fig. 7E, and Table 1), and they were
often found immediately adjacent to quail vessels (Fig. 7F).
Thus, in general, endothelial cells/progenitors derived from
VEGF-A/ EBs migrated and patterned properly in the
quail hosts. The difference between Type 1 and Type 2
VEGF-A/ grafts suggests that larger EBs are less amena-
ble to rescue by signals from the quail host, perhaps because
the host signals have difficulty penetrating to vascular cells
in the larger EBs.
Interestingly, ES cell-derived endothelial cells/progeni-
tors from VEGF-A/ grafts crossed the midline and colo-
nized the contralateral side much less frequently than did
their wild-type counterparts (Table 1). Midline crossing
between wild-type grafts and those of Type 1 VEGF-A/
grafts that have roughly equivalent numbers of graft-derived
endothelial cells and extensive migration were compared.
Mutant endothelial cells were found on the contralateral
side 13% of the time (1 of 8), whereas wild-type endothelial
cells were found on the contralateral side 35% of the time (6
of 17). Thus, Type 1 VEGF-A/ ES cell-derived endothe-
lial cells/progenitors more closely resemble presomitic me-
soderm-derived endothelial cells that never cross the host
embryonic midline (0 of 17; Ambler et al., 2001). This
result suggests that expression of VEGF-A by wild-type
graft EBs can interfere with host midline patterning signals
in a dominant manner, since abrogation of VEGF-A expres-
sion from the graft cells restores proper signaling at the host
embryonic midline.
Discussion
Our data strongly support a model of vascular patterning
in which instructive spatiotemporal information is provided
by signals from the embryonic environment (Fig. 8). In this
model, the target angioblasts and endothelial cells are made
competent to respond to these cues by the expression of
receptors, including the VEGF receptor flk-1. This require-
Table 1
Location of mouse graft vascular cells in quail hosts at 72–96 h
Graft type Area containing graft endothelial cells
Intersomitic Perineural Limbb Kidneyb Contralateral side
WT PSMa 76% (13/17) 100% (17/17) 83% (10/12) 100% (17/17) 0% (0/17)
WT EB 82% (14/17) 82% (14/17) 70% (7/10) 70% (7/10) 35% (6/17)
Flk-1/ EB 0% (0/9) 0% (0/9) 0% (0/9) 0% (0/9) 0% (0/9)
VEGF/ EB Type 1 100% (8/8) 88% (7/8) 86% (6/7) 75% (3/4) 13% (1/8)
VEGF/ EB Type 2 0% (0/7) 43% (3/7) 20% (1/5) 20% (1/5) 0% (0/7)
a Wild-type presomitic mesoderm grafts (from Ambler et al., 2001).
b Not all grafts were positioned to contribute to the limb and/or kidney areas.
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ment suggests that one or more flk-1 ligands contribute to
the host vascular patterning signals. The data supporting
this model are: (1) both somite-derived and ES cell-derived
endothelial cells/progenitors pattern similarly when placed
in the presomitic mesoderm cavity of an avian host; (2)
expression of the VEGF receptor flk-1 on target cells is
required for proper migration and patterning; and (3)
VEGF-A expression by target cells is not essential, and in
fact, ectopic expression of VEGF-A by graft cells interferes
with normal patterning at the embryonic midline. This
model provides a framework for further dissection of vas-
cular patterning information, and it has implications for
therapeutic approaches to vascular disease.
The remarkable similarity between the patterning behav-
ior of mouse somite-derived and ES cell-derived endothelial
cells/progenitors (Ambler et al., 2001; and this work)
strongly indicates that embryonic vascular cells from dif-
ferent sources mature through a similar stage where they are
competent to respond to most environmental patterning
cues. Alternatively, angioblasts from different sources could
have different intrinsic developmental programs that specify
responses to different subsets of vascular patterning cues.
Since ES cells are totipotent, they may be unique in their
ability to respond to a wider range of patterning cues than
endothelial cells/progenitors derived from specific embry-
onic locations. However, grafts from different tissues placed
heterotopically in quail-chick chimeras provide migratory
angioblasts that form vessels (Noden, 1989; Poole and Cof-
fin, 1989; Wilms et al., 1991; Pardanaud et al., 1996). Also,
we have anecdotally noted that mouse somite grafts placed
ectopically into mouse hosts form vessels in places where
host vessels are predicted to form (V.L.B., unpublished
results). These findings support the hypothesis that angio-
blasts from diverse locations can be made competent to
respond to local vascular patterning cues.
Vascular patterning signals are likely to emanate from
several embryonic structures. The consistent colonization of
host vascular beds in the kidney, limb, perineural, and
intersomitic areas by graft-derived vascular cells (Ambler et
al., 2001; and this work) suggests that local vascular pat-
terning cues are associated with structures in these areas,
such as the neural tube and the limb. What could these
patterning signals be? The inability of flk-1/ graft cells to
migrate and pattern in the avian host suggests that a ligand
of this receptor is a critical component of one or more
vascular patterning signals. VEGF-A, VEGF-C, and
VEGF-D are flk-1 ligands that could provide patterning
information in vivo (reviewed in Ferrara and Davis-Smyth,
1997). The expression patterns of all three ligands in avian
embryos support a possible role in vascular patterning
around the axial midline: VEGF-A is expressed in the neu-
ral tube and somites, VEGF-C is expressed in the kidney
rudiment and myotome, and VEGF-D is expressed in the
medial sclerotome (Aitkenhead et al., 1998; Eichmann et
al., 1998; Trelles et al., 2002). Further support for the
involvement of VEGF-A in patterning vessels is its role in
the skin and in the retina (Stone et al., 1995; Mukuoyama et
al., 2002). In these studies, the effects of VEGF-A were
local and selectively affected the patterning of arteries. In
contrast, VEGF-A appears to provide a long-range signal in
Xenopus and zebrafish to pattern the dorsal aorta at the
midline (Cleaver and Krieg, 1998; Liang et al., 2001). It will
be interesting to determine how VEGF-A acts in vascular
pattern formation around the mammalian axial midline.
One caveat to the interpretation that flk-1 is required for
endothelial cells/progenitors to respond to vascular pattern-
ing cues is that nonpatterning aspects of vascular develop-
ment are also compromised in the absence of flk-1. Flk-
1/ embryos and EBs make very few endothelial cells and
blood vessels. However, several lines of evidence indicate
that flk-1 is not absolutely required for angioblast differen-
tiation. Initial formation of some vessels is seen in flk-1/
mouse EBs and embryos, and zebrafish embryos lacking
flk-1 make many vessels but have defects in angiogenic
sprouting (Shalaby et al., 1995, 1997; Schuh et al., 1999;
Habeck et al., 2002). Moreover, the flk-1/ EBs and EB
grafts in our study had reasonable numbers of cells that
activated the flk-1 promoter (see Fig. 5A and B) and ex-
pressed PECAM (see Fig. 1D and Fig. 6A and B), both
hallmarks of murine angioblasts. Thus, it is likely that at
least a subset of angioblasts was available to respond to host
patterning cues. However, we cannot formally rule out that
flk-1 may be indirectly required for vascular patterning via
a role in establishing angioblast competence to respond to
vascular patterning signals. Conditional targeting strategies
and site-directed mutagenesis of the flk-1 receptor are
among the approaches that should clarify the role of flk-1 in
vascular patterning responses.
In contrast to the cell-autonomous requirement for flk-1,
VEGF-A expression by EB grafts is not required for proper
migration and patterning of graft-derived vascular cells. EB
grafts lacking VEGF-A (VEGF-A/) produce endothelial
cells/progenitors that migrate and pattern properly. This
finding is consistent with a non-cell-autonomous role for
VEGF-A in these processes that can be supplied by one or
more host-derived factors. It is intriguing that small EBs
(Type 1) produce vascular cells that pattern essentially like
WT EB grafts, whereas larger EBs (Type 2) produce fewer
vascular cells that pattern with lower frequency than WT
EB grafts. It may be that host-derived vascular patterning
signals are more accessible to angioblasts embedded in
smaller EBs, while the larger EBs attenuate the effective-
ness of host signals. Alternatively, the larger EBs may be
more mature and their vascular cells may be less responsive
to host-derived vascular patterning signals. These effects
would not be obvious in wild-type EBs that produce
VEGF-A throughout differentiation. Both scenarios suggest
that there may be spatial restrictions on the effectiveness of
signals, and/or temporal windows of angioblast competence
to respond to vascular patterning signals. The identity of the
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Fig. 5. Flk-1 graft-derived EB cells localize outside grafts at early time points. Flk-1/ EBs were labeled with CM-Dil (red) before implantation into a
quail host. Chimeric embryos were fixed at 18 (A), 24 (B, D–L), or 36 h (C) postsurgery and reacted for -gal (blue). (A–F) Whole mounts. (G–L) Transverse
sections. (A) EB graft, showing placement in the somitic area of the avian host. Day 3 EBs were placed into a 12-somite (HH stage 11) host, and incubated
for 18 h, to HH stage 17. The inset shows a higher magnification of the area adjacent to the graft, and the arrow indicates -gal cells that appear outside
the putative perimeter of graft. (B) EB graft, showing -gal cells that appear outside the putative graft perimeter (white dashed line). Day 3 EBs were placed
into a 19-somite (HH stage 13) host, and incubated for 24 h, to HH stage 20. The arrow indicates -gal cells that appear outside the putative graft perimeter.
(C) EB graft, showing -gal cells that appear outside the putative graft perimeter (white dashed line). Day 3 EBs were placed into a 19-somite (HH stage
13) host, and incubated for 36 h, to HH stage 21. The arrows indicate -gal cells that appear outside the putative graft perimeter. (D–F) EB graft after 24 h.
Day 3 EBs were placed into a 19-somite (HH stage 13) host, and incubated for 24 h, to HH stage 20. (D) Brightfield image. (E) Epifluorescence. (F) Merged
view. Dashed line denotes EB graft perimeter, and the arrows in (D) and (F) indicate -gal cells outside the graft perimeter. (G–L) Transverse sections of
chimeric embryos 24 h postsurgery viewed in bright field (G, J), epifluorescence (H, K), or merged (I, L). In (G), (I), (J), and (L), the arrows mark -gal
cells outside the graft perimeter, and the arrowheads mark -gal cells inside the graft perimeter. Scale bar, 20 m.
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host-derived signals that rescue ES cell-derived vascular
patterning is not formally known, but it is likely that avian
VEGF family members contribute to this rescue.
The patterning of vascular endothelial cells relative to
the embryonic midline is an interesting and somewhat mys-
terious process. Analysis of quail-chick chimeras shows that
somite-derived avian endothelial cells do not cross the em-
bryonic midline to colonize the contralateral side of the
host, except when the notochord is removed (Wilting et al.,
1995; Klessinger and Christ, 1996; Pardanaud et al., 1996).
We have recently extended these results to mouse endothe-
lial cells using mouse-avian chimeras (Ambler et al., 2001;
and C.A.A. and V.L.B., unpublished results). Thus, the
embryonic midline, which is established at gastrulation,
maintains a barrier to endothelial cell crossing that requires
an intact notochord for maintenance. We were initially quite
surprised to find that ES cell-derived endothelial cells/pro-
genitors derived from EB grafts crossed the host midline
Fig. 6. Mutant EB grafts display both cell-autonomous and non-cell-autonomous patterning defects in avian hosts. EB–avian chimeras made with either
flk-1/ (A, B) or VEGF-A/ (C–E) EBs were whole-mount stained for -gal (blue) reactivity (A, B) or with PECAM (brown) (C–E) to visualize
graft-derived vascular cells. (A, B) Two different examples of flk/ grafts showing graft-derived cells that express -gal from the flk-1 promoter but do not
migrate extensively. Dashed lines outline the limb in each panel. (A) Day 4 EBs were placed into a 15-somite (HH stage 12) host, and incubated for 3 days,
to HH stage 24. The arrow points to -gal-positive graft cells embedded within the chimeric embryo. (B) Day 4 EBs were placed into a 17-somite (HH stage
12) host, and incubated for 3 days, to HH stage 24. The inset shows a higher magnification of the graft site. (C, D) Two different examples of VEGF/
Type 1 grafts showing extensive dispersal of graft-derived vascular cells. In both cases, day 4 EBs were placed into a 14-somite (HH stage 11) host, and
incubated for 3 days, to HH stage 24. The dashed lines in (C) outline the limb. The boxed areas of each panel are shown at higher magnification in the insets,
which show the extensive graft-derived vasculature. (E) An example of a VEGF/ Type 2 graft showing some dispersal of graft-derived vascular cells that
remain in small clumps. Day 4 EBs were placed into a 12-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The inset shows a higher
magnification of the same graft, and the arrows point to small clumps of PECAM angioblasts.
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Fig. 7. Mutant ES cell-derived endothelial cells display both cell-autonomous and non-cell-autonomous patterning defects in avian hosts. EB–avian chimeras
made with either flk-1/ (A, B) or VEGF-A/ (C–F) mutant EBs were whole-mount stained for PECAM (brown) reactivity to visualize graft-derived
vascular cells, and transverse sections were then counterstained with QH1 (purple) to visualize host blood vessels. (A, B) Different areas of a Flk/ graft
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significantly more often than did somitic mesoderm-derived
endothelial cells/progenitors (see Table 1). This result sug-
gested that either ES cell-derived endothelial cells/progen-
itors differed from embryonic endothelial cells/progenitors
in their ability to sense and respond to the midline barrier or
that the host midline had been compromised.
The latter hypothesis is supported by our finding that ES
cell-derived endothelial cells/progenitors from VEGF-A/
EBs respected the midline barrier much more faithfully than
did their wild-type counterparts. While this result does not
formally rule out a cell-autonomous role for VEGF-A in
midline sensing or barrier crossing, it is most consistent
with a model in which VEGF-A signaling from nonendo-
thelial cells in the EB graft disrupts the host midline and
allows for midline crossing of graft cells (Fig. 8). Among
the cell types that form during EB formation is visceral
endoderm that is a potent source of VEGF-A expression
(Keller et al., 1993; Leahy et al., 1999). This layer forms the
outer layer of the EBs, analogous to its position in the yolk
sac, and thus it would likely be the outermost layer of the
EB grafts in avian hosts. From this position, VEGF-A could
be secreted and diffuse to the host midline, where it may
Fig. 8. Model of patterning interactions in EB–avian chimeric embryos. Schematic of a transverse section of an EB–avian chimera showing the migration
and colonization patterns of ES cell-derived endothelial cells/progenitors in avian hosts. It also depicts one possible molecular scenario that is consistent with
the data. The host neural tube produces a positive vascular patterning signal (orange arrows, VEGF?), and this signal acts on ES-cell derived endothelial/
progenitors that express the VEGF receptor flk-1 (red cells, flk-1) to promote migration and patterning (dashed white arrows). At the same time, a restrictive
vascular patterning signal emanates from the host midline (black stop lines, pink question marks) and prevents midline crossing of vascular cells. This signal,
however, can be compromised by ectopic VEGF-A expression (yellow arrows, VEGF) so that endothelial cells/progenitors can cross the vascular midline
(yellow X at midline). CV, cardinal vein; DA, dorsal aorta; DM, dermamyotome; EB, embryoid body; ML, midline; NC, notochord; NT, neural tube.
showing small clumps of graft-derived angioblasts independent of host vessels. Day 4 EBs were placed into an 11-somite (HH stage 10) host, and incubated
for 3 days, to HH stage 24. The arrows point to small aggregates of angioblasts and arrowheads point to individual cells. Note the rounded morphology of
the PECAM angioblasts. (C, D) Different areas of a VEGF/ Type 1 graft showing extensive dispersal of graft-derived vascular cells, and placement in
vascular beds with host vessels. Day 4 EBs were placed into a 14-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The arrows in (C)
point to examples of areas where graft-derived endothelial cells are closely apposed to host vessels, and the arrowhead points to a small clump of graft-derived
angioblasts. The arrows in (D) point to examples of putative junctions between graft and host endothelial cells to make mosaic vessels. The inset shows a
higher magnification of such a junction. (E, F) VEGF/ Type 2 graft showing some dispersal of graft-derived vascular cells that generally are found in small
clumps. Day 4 EBs were placed into a 14-somite (HH stage 11) host, and incubated for 3 days, to HH stage 24. The arrows in (E) and (F) point to rare
areas where graft-derived endothelial cells appear to form a mosaic vessel, and the arrowheads in each panel point to a clump of graft-derived angioblasts.
NT, neural tube. Scale bars (A, C, E)  40 m; and (B, D, F and inset D)  10 m.
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disrupt the barrier and/or the ability of endothelial cells/
progenitors to sense the barrier. These findings do not rig-
orously demonstrate a requirement for VEGF-A in midline
barrier function, but they show that VEGF-A can disrupt the
barrier in a dominant fashion. However, the cell-autono-
mous requirement for flk-1 in vascular patterning coupled
with these results suggests that VEGF-A may be involved in
establishing and/or maintaining the midline barrier. Further
experimentation combining genetic reagents and embryo-
logical techniques should resolve some of these unanswered
questions.
In any case, the ability of ES cell-derived angioblasts and
endothelial cells to respond to local vascular patterning cues
suggests therapeutic approaches using stem cell-derived en-
dothelial cells. Recent work shows that ES-cell derived
endothelial cells can colonize host vessels when directly
injected into the heart, and that ES cell-derived endothelial
cells form vessels in tumors when coinjected with tumor
cells (Yamashita et al., 2000; Marchetti et al., 2002). How-
ever, these studies did not address the patterning potential of
ES cell-derived angioblasts. Our work suggests that, if a
source of angioblasts were placed near a potential vascular-
ization site in vivo, the vascular patterning cues intrinsic to
the local environment might instruct the proper homing and
patterning of the therapeutic angioblasts. Conversely, dis-
ruption of local vascular patterning cues may disrupt the
surrounding vasculature and prevent proper vascular pat-
terning. This scenario is supported by recent work showing
that ectopic delivery of VEGF disrupts vessel blood forma-
tion in the local environment (Springer et al., 2000). Thus,
EB–avian chimeric embryos will be useful to further test
models of embryonic vascular patterning pathways, and
these pathways are likely to be important in therapeutic
vascularization as well. It should also provide a relatively
efficient way to test a subset of the numerous mutations that
have been generated in ES cells for their effect on vascular
patterning.
Acknowledgments
We thank Guo-Hua Fong, Janet Rossant, and Elizabeth
Robertson for the flt-1/, flk-1/, and ROSA26/ ES
cells, respectively. We thank members of the Bautch Lab
for fruitful discussions and an anonymous reviewer for
cogent comments, and Susan Whitfield for artwork and
photography. The QH1 monoclonal antibody developed by
F. Dieterlen-Lievre was obtained from the Developmental
Studies Hybridoma Bank under the auspices of the NICHD
and maintained by The University of Iowa, Department of
Biological Sciences, Iowa City, IA. The work was sup-
ported by a grant from the NIH (HL43174) to
V.L.B. G.M.S. received a James Henley Thompson and
Evelyn Barnett Thompson Undergraduate Research Award.
References
Aitkenhead, M., Christ, B., Eichmann, A., Feucht, M., Wilson, D.J., Wilt-
ing, J., 1998. Paracrine and autocrine regulation of vascular endothelial
growth factor during tissue differentiation in the quail. Dev. Dyn. 212,
1–13.
Ambler, C.A., Nowicki, J.L., Burke, A.C., Bautch, V.L., 2001. Assembly
of trunk and limb blood vessels involves extensive migration and
vasculogenesis of somite-derived angioblasts. Dev. Biol. 234, 352–
364.
Baldwin, H.S., Shen, H.M., Yan, H.C., DeLisser, H.M., Chung, A., Mic-
kanin, C., Trask, T., Kirschbaum, N.E., Neuman, P.J., Albelda, S.M.,
Buck, C.A., 1994. Platelet endothelial cell adhesion molecule-1 (PE-
CAM/CD31): alternatively spliced, functionally distinct isoforms ex-
pressed during mammalian cardiovascular development. Development
120, 2539–2553.
Bautch, V. L., 2002. Turksen, K. (Ed.), Embryonic stem cell differentiation
and the vascular lineage, in: Embryonic Stem Cells: Methods and
Protocols, Humana Press, Totowa, NJ, pp. 117–125.
Bautch, V.L., Redick, S.D., Scalia, A., Harmaty, M., Carmeliet, P., Rap-
oport, R., 2000. Characterization of the vasculogenic block in the
absence of vascular endothelial growth factor-A. Blood 95, 1979–
1987.
Beddington, R.S.P., Morgernstern, J., Land, H., Hogan, A., 1989. An in
situ transgenic enzyme marker for the midgestation mouse embryo and
the visualization of inner cell mass clones during early organogenesis.
Development 106, 37–46.
Childs, S., Chen, J.-N., Garrity, D.M., Fishman, M.C., 2002. Patterning of
angiogenesis in the zebrafish embryo. Development 129, 973–982.
Clark, E.R., Clark, E.L., 1939. Microscopic observations on the growth of
blood capillaries in the living mammal. Am. J. Anat. 64, 251–299.
Cleaver, O., Krieg, P.A., 1998. VEGF mediates angioblast migration dur-
ing development of the dorsal aorta in Xenopus. Development 125,
3905–3914.
Daniel, T.O., Abrahamson, D., 2000. Endothelial signal integration in
vascular assembly. Annu. Rev. Physiol. 62, 649–671.
Dent, J.A., Polson, A.G., Klymkowsky, M.W., 1989. A whole-mount
immunocytochemical analysis of the expression of the intermediate
filament protein vimentin in Xenopus. Development 105, 61–74.
Drake, C.J., Hungerford, J.E., Little, C.D., 1998. Morphogenesis of the first
blood vessels. in: Fleischmajer, R., Timpl, R., Werb, Z. (Eds.), Mor-
phogenesis: Cellular Interactions. N. Y., Acad, Sci., New York, pp.
155–180.
Eichmann, A., Corbel, C., Jaffredo, T., Breant, C., Jouko, V., Kumar, V.,
Alitalo, K., Le Douarin, N.M., 1998. Avian VEGF-C: cloning, embry-
onic expression pattern and stimulation of the differentiation of
VEGFR2-expressing endothelial cell precursors. Development 125,
743–752.
Ferrara, N., Davis-Smyth, T., 1997. The biology of vascular endothelial
growth factor. Endocr. Rev. 18, 4–25.
Fong, G.-H., Rossant, J., Gertsenstein, M., Breitman, M.L., 1995. Role of
the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular
endothelium. Nature 376, 66–70.
Fong, G.H., Klingensmith, J., Wood, C.R., Rossant, J., Breitman, M.L.,
1996. Regulation of flt-1 expression during mouse embryogenesis sug-
gests a role in the establishment of vascular endothelium. Dev. Dyn.
207, 1–10.
Fong, G.H., Zhang, L., Bryce, D.M., Peng, J., 1999. Increased hemangio-
blast commitment, not vascular disorganization, is the primary defect in
flt-1 knock-out mice. Development 126, 3015–3025.
Graef, I.A., Chen, F., Chen, L., Kuo, A., Crabtree, G.R., 2001. Signals
transduced by Ca2/calcineurin and NFATc3/c4 pattern the developing
vasculature. Cell 105, 863–875.
Habeck, H., Odenthal, J., Walderich, B., Maischein, H.-M., Tubingen 2000
screen consortium and Schulte-Merker, S. 2002. Analysis of a zebrafish
218 C.A. Ambler et al. / Developmental Biology 257 (2003) 205–219
VEGF receptor mutant reveals specific disruption of angiogenesis.
Curr. Biol. 12, 1405–1412.
Hamburger, V., Hamilton, H.L., 1951. A series of normal stages in the
development of the chick embryo. J. Morphol. 88, 49–92.
Hogan, B.L.M., Kolodziej, P.A., 2002. Molecular mechanisms of tubulo-
genesis. Nat. Rev. Genet. 3, 513–523.
Kearney, J.B., Ambler, C.A., Monaco, K.A., Johnson, N., Rapoport, R.G.,
Bautch, V.L., 2002. Vascular endothelial growth factor receptor Flt-1
negatively regulates developmental blood vessel formation by modu-
lating endothelial cell division. Blood 99, 2397–2407.
Keller, G., Kennedy, M., Papayannopoulou, T., Wiles, M., 1993. Hema-
topoietic commitment during embryonic stem cell differentiation in
culture. Mol. Cell. Biol. 13, 473–486.
Klessinger, S., Christ, B., 1996. Axial structures control laterality in the
distribution pattern of endothelial cells. Anat. Embryol. 193, 319–330.
Leahy, A., Xiong, J.-W., Kuhnert, F., Stuhlmann, H., 1999. Use of devel-
opmental marker genes to define temporal and spatial patterns of
differentiation during embryoid body formation. J. Exp. Zool. 284,
67–81.
Liang, D., Chang, J.R., Chin, A.J., Smith, A., Kelly, C., Weinberg, E.S.,
Ge, R., 2001. The role of vascular endothelial growth factor (VEGF) in
vasculogenesis, angiogenesis, and hematopoiesis in zebrafish develop-
ment. Mech. Dev. 108, 29–43.
Marchetti, S., Gimond, C., Iljin, K., Bourcier, C., Alitalo, K., Pouyssegur,
J., Pages, G., 2002. Endothelial cells genetically selected from differ-
entiating mouse embryonic stem cells incorporate at sites of neovas-
cularization in vivo. J. Cell Sci. 115, 2075–2085.
Mukuoyama, Y., Shin, D., Britsch, S., Taniguchi, M., Anderson, D.J.,
2002. Sensory nerves determine the pattern of arterial differentiation
and blood vessel branching in the skin. Cell 109, 693–705.
Noden, D.M., 1989. Embryonic origins and assembly of blood vessels.
Am. Rev. Respir. Dis. 140, 1097–1103.
Orlidge, A., D’Amore, P.A., 1987. Inhibition of capillary endothelial cell
growth by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455–
1462.
Otani, A., Kinder, K., Ewalt, K., Otero, F.J., Schimmel, P., Friedlander, M.,
2002. Bone marrow-derived stem cells target retinal astrocytes and can
promote or inhibit retinal angiogenesis. Nat. Med. 8, 1004–1010.
Pardanaud, L., Altmann, C., Kitos, P., Dieterlen-Lievre, F., Buck, C.A.,
1987. Vasculogenesis in the early quail blastodisc as studied with a
monoclonal antibody recognizing endothelial cells. Development 100,
339–349.
Pardanaud, L., Luton, D., Prigent, M., Bourcheix, L.-M., Catala, M., Dieterlen-
Lievre, F., 1996. Two distinct endothelial lineages in ontogeny, one of
them related to hemopoiesis. Development 122, 1363–1371.
Pereria, F.A., Qiu, Y., Zhou, G., Tsai, M.-J., Tsai, S. Y., 1999. The orphan
nuclear receptor COUP-TFII is required for angiogenesis and heart
development. Genes Dev. 13, 1037–1049.
Poole, T.J., Coffin, D., 1989. Vasculogenesis and angiogenesis: two dis-
tinct morphogenetic mechanisms establish embryonic vascular pattern.
J. Exp. Zool. 251, 224–231.
Redick, S.D., Bautch, V.L., 1999. Developmental platelet endothelial cell
adhesion molecule expression suggests multiple roles for a vascular
adhesion molecule. Am. J. Pathol. 154, 1137–1147.
Risau, W., 1997. Mechanisms of angiogenesis. Nature 386, 671–674.
Sabin, F.R., 1917. Origin and development of the primitive vessels of the
chick and of the pig. Contrib. Embryol. Carnegie Inst. 6, 61–124.
Schuh, A.C., Faloon, P., Hu, Q.-L., Bhimani, M., Choi, K., 1999. In vitro
hematopoietic and endothelial potential of flk-1/ embryonic stem
cells and embryos. Proc. Natl. Acad. Sci. USA 96, 2159–2164.
Shalaby, F., Ho, J., Stanford, W.L., Fischer, K.-D., Schuh, A.C., Schwartz,
L., Bernstein, A., Rossant, J., 1997. A requirement for Flk1 in primitive
and definitive hematopoiesis and vasculogenesis. Cell 89, 981–990.
Shalaby, F., Rossant, J., Yamaguchi, T., Gertsenstein, M., Wu, X.-F.,
Breitman, M.L., Schuh, A.C., 1995. Failure of blood-island formation
and vasculogenesis in Flk-1- deficient mice. Nature 376, 62–66.
Springer, M.L., Hortelano, G., Bouley, D.M., Wong, J., Kraft, P.E., Blau,
H.M., 2000. Induction of angiogenesis by implantation of encapsulated
primary myoblasts expressing vascular endothelial growth factor.
J. Gene Med. 2, 279–288.
Stone, J., Itin, A., Alon, T., Pe’er, J., Gnessin, H., Chan-Ling, T., Keshet,
E., 1995. Development of retinal vasculature is mediated by hypoxia-
induced vascular endothelial growth factor (VEGF) expression by
neuroglia. J. Neurosci. 15, 4738–4747.
Trelles, R.D., Leon, J.R., Kawakami, Y., Simoes, S., Izpisua-Belmonte,
J.C., 2002. Expression of the chick vascular endothelial growth factor
D gene during limb development. Mech. Dev. 116, 239–242.
Vittet, D., Prandini, M.H., Berthier, R., Schweitzer, A., Martin-Sisteron,
H., Uzan, G., Dejana, E., 1996. Embryonic stem cells differentiate in
vitro to endothelial cells through successive maturation steps. Blood
88, 3424–3431.
Wang, R., Clark, R., Bautch, V.L., 1992. Embryonic stem cell-derived
cystic embryoid bodies form vascular channels: an in vitro model of
blood vessel development. Development 114, 303–316.
Wilms, P., Christ, B., Wilting, J., Wachtler, F., 1991. Distribution and
migration of angiogenic cells from grafted avascular intraembryonic
mesoderm. Anat. Embryol. 183, 371–377.
Wilting, J., Brand-Saberi, B., Huang, R., Zhi, Q., Kontges, G., Ordahl,
C.P., Christ, B., 1995. Angiogenic potential of the avian somite. Dev.
Dyn. 202, 165–171.
Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi,
T., Naito, M., Nakao, K., Nishikawa, S.-I., 2000. Flk-1 positive cells
derived from embryonic stem cells serve as vascular progenitors. Na-
ture 408, 92–96.
Zhang, Y., Porat, R.M., Alon, T., Keshet, E., Stone, J., 1999. Tissue
oxygen levels control astrocyte movement and differentiation in devel-
oping retina. Dev. Brain Res. 118, 135–145.
Zhong, T.P., Rosenberg, M., Mohideen, M.-A.P.K., Weinstein, B., Fish-
man, M.C., 2000. Gridlock, an HLH gene required for assembly of the
aorta in zebrafish. Science 287, 1820–1824.
219C.A. Ambler et al. / Developmental Biology 257 (2003) 205–219
